Kurtis E Sobkowich, Angela Y Hui, Zvonimir Poljak, Donald Szlosek, Andy Plum, J Scott Weese
{"title":"Nationwide analysis of methicillin-resistant staphylococci in cats and dogs: resistance patterns and geographic distribution.","authors":"Kurtis E Sobkowich, Angela Y Hui, Zvonimir Poljak, Donald Szlosek, Andy Plum, J Scott Weese","doi":"10.2460/ajvr.24.09.0253","DOIUrl":null,"url":null,"abstract":"<p><strong>Objective: </strong>This study aims to quantify the frequency and resistance patterns of 3 methicillin-resistant staphylococci (MRS), Staphylococcus aureus (MRSA), Staphylococcus pseudintermedius (MRSP), and Staphylococcus schleiferi (MRSS), in companion animals, using historical culture and susceptibility data from a national diagnostic laboratory.</p><p><strong>Methods: </strong>Samples from cats and dogs across the US, between 2019 and 2022, were analyzed. Methicillin-resistant isolates identified according to Clinical and Laboratory Standards Institute VET01S (5th ed) were included. Data included location, patient species, sampling site, year, and susceptibility results for various panels of antimicrobials.</p><p><strong>Results: </strong>There were 110,423 MRSP, 5,618 MRSA, and 20,934 MRSS isolates identified. Methicillin-resistant S pseudintermedius was predominantly found in dogs (96.2%), with skin and soft tissue being the most common sites. Methicillin-resistant S aureus and MRSS were also primarily isolated from dogs, with significant yearly, regional, and species-specific differences in antimicrobial susceptibility observed. This study highlights high resistance levels in MRSP isolates, while MRSA and MRSS showed relatively higher susceptibility to several antimicrobials.</p><p><strong>Conclusions: </strong>This study provides insight into the distribution and antimicrobial resistance patterns of MRSA, MRSP, and MRSS in companion animals in the US. Resistance rates for enrofloxacin, marbofloxacin, and chloramphenicol may be higher than reported in this analysis due to recent changes in MIC breakpoints in the Clinical and Laboratory Standards Institute VET01S (7th ed). The findings underscore significant geographical and temporal variations in resistance, emphasizing the need for tailored antimicrobial stewardship programs.</p><p><strong>Clinical relevance: </strong>The prevalence of MRS in companion animals poses treatment challenges and potential zoonotic risks. This study provides nationwide insight that was not previously available.</p>","PeriodicalId":7754,"journal":{"name":"American journal of veterinary research","volume":" ","pages":""},"PeriodicalIF":1.4000,"publicationDate":"2025-02-10","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"American journal of veterinary research","FirstCategoryId":"97","ListUrlMain":"https://doi.org/10.2460/ajvr.24.09.0253","RegionNum":3,"RegionCategory":"农林科学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"2025/3/1 0:00:00","PubModel":"Print","JCR":"Q2","JCRName":"VETERINARY SCIENCES","Score":null,"Total":0}
引用次数: 0
Abstract
Objective: This study aims to quantify the frequency and resistance patterns of 3 methicillin-resistant staphylococci (MRS), Staphylococcus aureus (MRSA), Staphylococcus pseudintermedius (MRSP), and Staphylococcus schleiferi (MRSS), in companion animals, using historical culture and susceptibility data from a national diagnostic laboratory.
Methods: Samples from cats and dogs across the US, between 2019 and 2022, were analyzed. Methicillin-resistant isolates identified according to Clinical and Laboratory Standards Institute VET01S (5th ed) were included. Data included location, patient species, sampling site, year, and susceptibility results for various panels of antimicrobials.
Results: There were 110,423 MRSP, 5,618 MRSA, and 20,934 MRSS isolates identified. Methicillin-resistant S pseudintermedius was predominantly found in dogs (96.2%), with skin and soft tissue being the most common sites. Methicillin-resistant S aureus and MRSS were also primarily isolated from dogs, with significant yearly, regional, and species-specific differences in antimicrobial susceptibility observed. This study highlights high resistance levels in MRSP isolates, while MRSA and MRSS showed relatively higher susceptibility to several antimicrobials.
Conclusions: This study provides insight into the distribution and antimicrobial resistance patterns of MRSA, MRSP, and MRSS in companion animals in the US. Resistance rates for enrofloxacin, marbofloxacin, and chloramphenicol may be higher than reported in this analysis due to recent changes in MIC breakpoints in the Clinical and Laboratory Standards Institute VET01S (7th ed). The findings underscore significant geographical and temporal variations in resistance, emphasizing the need for tailored antimicrobial stewardship programs.
Clinical relevance: The prevalence of MRS in companion animals poses treatment challenges and potential zoonotic risks. This study provides nationwide insight that was not previously available.
期刊介绍：
The American Journal of Veterinary Research supports the collaborative exchange of information between researchers and clinicians by publishing novel research findings that bridge the gulf between basic research and clinical practice or that help to translate laboratory research and preclinical studies to the development of clinical trials and clinical practice. The journal welcomes submission of high-quality original studies and review articles in a wide range of scientific fields, including anatomy, anesthesiology, animal welfare, behavior, epidemiology, genetics, heredity, infectious disease, molecular biology, oncology, pharmacology, pathogenic mechanisms, physiology, surgery, theriogenology, toxicology, and vaccinology. Species of interest include production animals, companion animals, equids, exotic animals, birds, reptiles, and wild and marine animals. Reports of laboratory animal studies and studies involving the use of animals as experimental models of human diseases are considered only when the study results are of demonstrable benefit to the species used in the research or to another species of veterinary interest. Other fields of interest or animals species are not necessarily excluded from consideration, but such reports must focus on novel research findings. Submitted papers must make an original and substantial contribution to the veterinary medicine knowledge base; preliminary studies are not appropriate.
京公网安备 11010802042870号
京ICP备2023020795号-1
分享
求助内容：
应助结果提醒方式：
扫码关注我们
